Physician profile

Robert Michael Holtrup

Physician Assistant · Dayton, OH

NPI 1669604609

$3,844.67

in general payments reported to CMS, 2019-2025

35 companies · $1,594 in 2025

The $1,594 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,456.58

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astrazeneca Pharmaceuticals LP $852.59 2023-2025 Breztri, Tezspire, Farxiga
Abbvie INC. $584.78 2023-2025
Dexcom, INC. $276.35 2024-2025 Dexcom G6 Transmitter
Novo Nordisk INC $244.95 2024-2025 Wegovy, Ozempic, Rybelsus
Merck Sharp & Dohme LLC $165.97 2021-2023 Vaxneuvance, Vaxelis, Gardasil 9
Amgen INC. $157.94 2023-2025 Repatha, Otezla, Repatha
Bayer Healthcare Pharmaceuticals INC. $133.33 2024-2025
Glaxosmithkline, LLC. $119.63 2021-2025 Bexsero, Trelegy Ellipta, Pediarix
Pfizer INC. $118.71 2021-2025
Exact Sciences Corporation $112.77 2024-2025 Cologuard Collection Kit, The Cologuard Plus Collection Kit
Astellas Pharma US INC $110.37 2024 Veozah
Cequr Corporation $97.75 2024-2025 Cequr Simplicity
Seqirus USA INC $86.50 2021-2023 Flucelvax Quadrivalent
Abbott Laboratories $76.91 2023-2024 Freestyle Libre 3
Amphastar Pharmaceuticals, INC. $71.69 2024-2025
Show all 35 companies
CompanyGeneral paymentsYearsTop products
Xeris Pharmaceuticals, INC. $67.72 2024-2025 Gvoke Hypopen
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $60.27 2025 Caplyta
Mylan Specialty L.P. $46.43 2024 Yupelri
Kowa Pharmaceuticals America, INC. $46.36 2025 Zoryve
Tempus Ai, INC $45.33 2024
Takeda Pharmaceuticals U.S.A., INC. $40.94 2021
Phadia US INC. $39.02 2023 Immunocap
Mannkind Corporation $38.22 2025
Sanofi Pasteur INC. $29.24 2021
Phathom Pharmaceuticals, INC. $28.56 2024-2025 Voquezna
Otsuka America Pharmaceutical, INC. $27.02 2023 Rexulti
Ironshore Pharmaceuticals INC. $26.35 2021-2022
Medtronic, INC. $26.21 2025 Venaseal
Genentech USA, INC. $20.26 2021
Pulmonx Corporation $18.52 2024 Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter
Vivaquant INC, Dba Rhythm Express $17.00 2025 Rhythm Express
Scilex Pharmaceuticals INC. $15.07 2025
Lilly USA, LLC $14.52 2024 Jardiance
Cranial Technologies, INC $13.70 2023 Doc Band
Boehringer Ingelheim Pharmaceuticals, INC. $13.69 2025 Jardiance

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Robert Michael Holtrup

$3,844.67

in general payments reported 2019-2025

Years
2021-2025
Top company
Astrazeneca Pharmaceuticals LP
Context
The $1,594 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).

https://glasscript.com/doctor/10894760/robert-michael-holtrup

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.